EUVIMEDEUVIMED entdecken
FallberichtStudienprotokollOpen Access · CC BY-NC-ND 4.0

IgM anti‐ MAG ± peripheral neuropathy ( IMAGiNe ) study protocol: An international, observational, prospective registry of patients with IgM M‐protein peripheral neuropathies

Tatiana Hamadeh iD, Perry T C van Doormaal iD, Mariëlle H J Pruppers, Johannes P M van de Mortel, Janneke G J Hoeijmakers, David R Cornblath, Alexander F J E Vrancken, Catharina G Faber, Nicolette C Notermans, Ingemar S J Merkies, IMAGiNe Consortium

Journal of the Peripheral Nervous System · 2023

DOI: 10.1111/jns.12547 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of the Peripheral Nervous System, 2023. Verfasst von Tatiana Hamadeh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Maastricht University Medical Center+, Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Peripheral Nervous System Diseases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: GBS/CIDP Foundation International.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

International consensus on IgM ± anti‐MAG ± PNP (IgM PNP) is lacking. Despite increasing interest in clinical trials, validated disease‐specific measures are needed to adequately capture limitations and changes over time. The IMAGiNe (IgM ± anti‐myelin associated glycoprotein [MAG] peripheral neuropathy) study surges as an international collaboration to create a standardized registry of patients with IgM ± anti‐MAG PNP. The consortium, which currently consists of 11 institutions from 7 countries, presents here the IMAGiNe study design and protocol.

Aims

Functional outcome measures will be constructed at the level of impairment, as well as activity and participation. We aim to describe the natural history of the cohort, the role of anti‐MAG antibodies, the presence of clinical subtypes, and potential biomarkers.

Methods

The IMAGiNe study is a prospective, observational cohort study with a 3‐year follow‐up. At each assessment, researchers collect clinical data and subjects complete a list of preselected outcome measures. Among these, the “Pre‐Rasch‐built Overall Disability Scale (Pre‐RODS)” questionnaire will be submitted to Rasch analysis to assess classic and modern clinimetric requirements.

Results

The final measures will include the IgM‐PNP‐specific RODS and Ataxia Rating Scale (IgM‐PNP‐ARS). Descriptions of the disease course, clinical heterogeneity, treatment regimes, variations in laboratory values, and antibody titers will help reach consensus on diagnosis and follow‐up strategies.

Conclusion

The constructed interval scales will be cross‐culturally valid and suitable for use in future clinical trials and daily practice. The ultimate goals are to improve functional individualized assessment, reach international consensus, and lay the foundations for successful designs in future studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peripheral Nervous System DiseasesHumansImmunoglobulin MMyelin-Associated GlycoproteinBiomarkersAutoantibodiesAtaxiaObservational Studies as Topic

Stichwörter der Autor:innen

IgM neuropathiesanti-MAG antibodiesclinimetrymonoclonal gammopathy of undetermined significanceparaproteinemic neuropathies

Substanzen

Immunoglobulin MMyelin-Associated GlycoproteinBiomarkersAutoantibodies

Autor:innen und Institutionen

  • Department of Neurology, Maastricht University Medical Center+, Maastricht, The Netherlands.
  • Department of Neurology, Brain Center Rudolph Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Department of Neurology, Tergooi Medical Center, Hilversum, The Netherlands.
  • Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA.
  • Department of Neurology, Curacao Medical Center, Willemstad, Curaçao.

ORCID-Profile: Tatiana Hamadeh, Perry T C van Doormaal

Förderung

  • GBS/CIDP Foundation International

Zitieren

APA

Hamadeh, T., van Doormaal, P. T. C., Pruppers, M. H. J., van de Mortel, J. P. M., Hoeijmakers, J. G. J., Cornblath, D. R., Vrancken, A. F. J. E., Faber, C. G., Notermans, N. C., Merkies, I. S. J., & IMAGiNe Consortium (2023). IgM anti‐ MAG ± peripheral neuropathy ( IMAGiNe ) study protocol: An international, observational, prospective registry of patients with IgM M‐protein peripheral neuropathies. Journal of the Peripheral Nervous System. https://doi.org/10.1111/jns.12547

Vancouver

Hamadeh T, van Doormaal PTC, Pruppers MHJ, van de Mortel JPM, Hoeijmakers JGJ, Cornblath DR, et al. IgM anti‐ MAG ± peripheral neuropathy ( IMAGiNe ) study protocol: An international, observational, prospective registry of patients with IgM M‐protein peripheral neuropathies. Journal of the Peripheral Nervous System. 2023. doi:10.1111/jns.12547

BibTeX
@article{Hamadeh2023,
  author = {Hamadeh, Tatiana and van Doormaal, Perry T C and Pruppers, Mariëlle H J and van de Mortel, Johannes P M and Hoeijmakers, Janneke G J and Cornblath, David R and Vrancken, Alexander F J E and Faber, Catharina G and Notermans, Nicolette C and Merkies, Ingemar S J and IMAGiNe Consortium, IMAGiNe Consortium},
  title = {IgM anti‐ MAG ± peripheral neuropathy ( IMAGiNe ) study protocol: An international, observational, prospective registry of patients with IgM M‐protein peripheral neuropathies},
  journal = {Journal of the Peripheral Nervous System},
  year = {2023},
  doi = {10.1111/jns.12547}
}
Kostenlos starten →